| Dr Edsel P Holden Ii, MD | |
|
3905 Peach St, Florence, AL 35630-2803 | |
| (256) 767-5864 | |
| (256) 263-4512 |
| Full Name | Dr Edsel P Holden Ii |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 36 Years |
| Location | 3905 Peach St, Florence, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013015254 | NPI | - | NPPES |
| 051507070 | Medicaid | AL | |
| P00076769 | Other | AL | RAILROAD MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Alabama Medical Center | Florence, AL | Hospital |
| Helen Keller Hospital | Sheffield, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Lung Center, Pc | 2961431895 | 2 |
News Archive
Prompted by an inquiry from GlobalPost, U.S. officials have said the Obama administration called for a $550 million reduction - an 11 percent cut - for its global AIDS program in its FY 2013 budget request because the "government didn't need more money because there has been nearly $1.5 billion stuck in the pipeline for 18 months or more," GlobalPost reports.
Containing costs while delivering high-quality, effective care is a directive of healthcare reform. Episode-based care is part of the reform mandate and is a payment approach that reimburses on expected costs for clinically defined episodes rather than fee-for-service.
Plexxikon Inc. today announced promising preclinical data from in vivo cancer studies with PLX3397 demonstrating significant reduction in tumor burden, metastatic spread, bone erosion and cancer bone pain. PLX3397 is an oral, selective kinase inhibitor that down-modulates macrophages, microglia, osteoclasts and mast cells, all cell types targeted by this drug candidate. These cell types play a key role in cancer and metastasis.
Advanced breast cancer patients who have failed prior endocrine treatment may receive a progression-free survival benefit if palbociclib is added to fulvestrant, a phase III trial indicates.
› Verified 5 days ago
| Entity Name | The Lung Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790887545 PECOS PAC ID: 2961431895 Enrollment ID: O20050810000848 |
News Archive
Prompted by an inquiry from GlobalPost, U.S. officials have said the Obama administration called for a $550 million reduction - an 11 percent cut - for its global AIDS program in its FY 2013 budget request because the "government didn't need more money because there has been nearly $1.5 billion stuck in the pipeline for 18 months or more," GlobalPost reports.
Containing costs while delivering high-quality, effective care is a directive of healthcare reform. Episode-based care is part of the reform mandate and is a payment approach that reimburses on expected costs for clinically defined episodes rather than fee-for-service.
Plexxikon Inc. today announced promising preclinical data from in vivo cancer studies with PLX3397 demonstrating significant reduction in tumor burden, metastatic spread, bone erosion and cancer bone pain. PLX3397 is an oral, selective kinase inhibitor that down-modulates macrophages, microglia, osteoclasts and mast cells, all cell types targeted by this drug candidate. These cell types play a key role in cancer and metastasis.
Advanced breast cancer patients who have failed prior endocrine treatment may receive a progression-free survival benefit if palbociclib is added to fulvestrant, a phase III trial indicates.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edsel P Holden Ii, MD 3905 Peach St, Florence, AL 35630-2803 Ph: (256) 767-5864 | Dr Edsel P Holden Ii, MD 3905 Peach St, Florence, AL 35630-2803 Ph: (256) 767-5864 |
News Archive
Prompted by an inquiry from GlobalPost, U.S. officials have said the Obama administration called for a $550 million reduction - an 11 percent cut - for its global AIDS program in its FY 2013 budget request because the "government didn't need more money because there has been nearly $1.5 billion stuck in the pipeline for 18 months or more," GlobalPost reports.
Containing costs while delivering high-quality, effective care is a directive of healthcare reform. Episode-based care is part of the reform mandate and is a payment approach that reimburses on expected costs for clinically defined episodes rather than fee-for-service.
Plexxikon Inc. today announced promising preclinical data from in vivo cancer studies with PLX3397 demonstrating significant reduction in tumor burden, metastatic spread, bone erosion and cancer bone pain. PLX3397 is an oral, selective kinase inhibitor that down-modulates macrophages, microglia, osteoclasts and mast cells, all cell types targeted by this drug candidate. These cell types play a key role in cancer and metastasis.
Advanced breast cancer patients who have failed prior endocrine treatment may receive a progression-free survival benefit if palbociclib is added to fulvestrant, a phase III trial indicates.
› Verified 5 days ago
Khushdeep Singh Chahal, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 205 Marengo Street, Florence, AL 35630 Phone: 256-768-9509 Fax: 256-768-9715 | |
John D Morris, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 205 Marengo Street, Florence, AL 35630 Phone: 256-768-9509 Fax: 256-768-9715 | |
Danny Wayne Mcfall, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 409 North Cedar Street, Florence, AL 35630 Phone: 256-766-3062 Fax: 256-767-1804 | |
Gabriel Hamilton Hester, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 205 Marengo St, Florence, AL 35630 Phone: 256-768-9509 Fax: 256-768-9715 | |
Dr. Rajesh Boorgu, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 422 E Dr Hicks Blvd, Florence, AL 35630 Phone: 256-766-1401 Fax: 256-766-1402 | |
Dr. Narasimha Rao Boorgu, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 422 E Dr Hicks Blvd, Florence, AL 35630 Phone: 256-766-1401 Fax: 256-766-1402 |